Expertise in
4
conditions

Dr. Michael Dunn

Cardiology | Pulmonary Medicine
Henry Ford West Bloomfield Hospital Laboratory
6777 W Maple Rd, 
West Bloomfield, MI 
Expertise in
4
conditions
Henry Ford West Bloomfield Hospital Laboratory
6777 W Maple Rd, 
West Bloomfield, MI 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Michael Dunn is a Cardiologist and a Pulmonary Medicine provider in West Bloomfield, Michigan. Dr. Dunn is highly rated in 4 conditions, according to our data. His top areas of expertise are Chronic Cough, Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), and Pneumonia.

His clinical research consists of participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Cardiology
Pulmonary Medicine
Licenses
Critical Care Medicine in MI
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Health Alliance Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
McLaren Health
  • HMO
Priority Health
  • HMO
  • POS
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 3 Less Insurance Carriers -

Locations

Henry Ford West Bloomfield Hospital Laboratory
6777 W Maple Rd, West Bloomfield, MI 48322
Other Locations
Office
39450 W 12 Mile Rd, Novi, MI 48377

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Phase 2 Study of ABP-450 (prabotulinumtoxinA) Purified Neurotoxin Complex for the Prevention of Migraine Headache
A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Phase 2 Study of ABP-450 (prabotulinumtoxinA) Purified Neurotoxin Complex for the Prevention of Migraine Headache
Enrollment Status: Completed
Publish Date: September 04, 2024
Intervention Type: Drug
Study Drug: ABP-450
Study Phase: Phase 2
Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo After an Intensive Lifestyle Program in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight-Related Comorbidities: A Randomized, Double Blind, Placebo-Controlled Trial (SURMOUNT-3)
Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo After an Intensive Lifestyle Program in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight-Related Comorbidities: A Randomized, Double Blind, Placebo-Controlled Trial (SURMOUNT-3)
Enrollment Status: Completed
Publish Date: May 16, 2024
Intervention Type: Other, Drug
Study Drug: Tirzepatide
Study Phase: Phase 3
A Randomized, Double-blind, Placebo-Controlled, Phase 2/3 Study to Evaluate the Efficacy and Safety of LY3819253 and LY3832479 in Participants With Mild to Moderate COVID-19 Illness
A Randomized, Double-blind, Placebo-Controlled, Phase 2/3 Study to Evaluate the Efficacy and Safety of LY3819253 and LY3832479 in Participants With Mild to Moderate COVID-19 Illness
Enrollment Status: Completed
Publish Date: April 11, 2024
Intervention Type: Drug
Study Drugs: Bamlanivimab, Etesevimab
Study Phase: Phase 2/Phase 3
A Randomized, Double-blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Mono and Combination Therapy With Monoclonal Antibodies in Participants With Mild to Moderate COVID-19 Illness (BLAZE-4)
A Randomized, Double-blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Mono and Combination Therapy With Monoclonal Antibodies in Participants With Mild to Moderate COVID-19 Illness (BLAZE-4)
Enrollment Status: Completed
Publish Date: July 01, 2022
Intervention Type: Drug
Study Drugs: Bamlanivimab, Etesevimab, LY3853113 Anti-COVID-19 Antibody, VIR-7831 Anti-COVID-19 Antibody
Study Phase: Phase 2
A Study of Three Doses of Lasmiditan (50 mg, 100 mg and 200 mg) Compared to Placebo in the Acute TReaTment of MigrAiNe: A Randomized, Double-blind, Placebo-controlled Parallel Group Study (SPARTAN)
A Study of Three Doses of Lasmiditan (50 mg, 100 mg and 200 mg) Compared to Placebo in the Acute TReaTment of MigrAiNe: A Randomized, Double-blind, Placebo-controlled Parallel Group Study (SPARTAN)
Enrollment Status: Completed
Publish Date: September 23, 2019
Intervention Type: Drug
Study Phase: Phase 3
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks
Enrollment Status: Completed
Publish Date: September 19, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 5 Less Clinical Trials
Similar Doctors
Expertise in
10
conditions
Dr. Justin M. Oldham
Pulmonary Medicine
Expertise in
10
conditions
Dr. Justin M. Oldham
Pulmonary Medicine

Regents Of The University Of Michigan

1500 E Medical Ctr, Suite 0331, 
Ann Arbor, MI 
 (21.0 miles away)
734-936-5738
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Justin Oldham is a Pulmonary Medicine provider in Ann Arbor, Michigan. Dr. Oldham is highly rated in 10 conditions, according to our data. His top areas of expertise are Acute Interstitial Pneumonia, Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, Pulmonary Fibrosis, and Lung Transplant. Dr. Oldham is currently accepting new patients.

Expertise in
15
conditions
Dr. Daniel Ouellette
Cardiology | Pulmonary Medicine
Expertise in
15
conditions
Dr. Daniel Ouellette
Cardiology | Pulmonary Medicine

Henry Ford Hospital

2799 W Grand Blvd, 
Detroit, MI 
 (20.1 miles away)
313-916-2600
Languages Spoken:
English
See accepted insurances

Daniel Ouellette is a Cardiologist and a Pulmonary Medicine provider in Detroit, Michigan. Dr. Ouellette is highly rated in 15 conditions, according to our data. His top areas of expertise are Sarcoidosis, Emphysema, Acute Interstitial Pneumonia, Endoscopy, and Gastrostomy.

Kim Eagle
Expertise in
40
conditions
Dr. Kim Eagle
Cardiology
Expertise in
40
conditions
Dr. Kim Eagle
Cardiology

Office

4029 Maria St Ste A, 
Ann Arbor, MI 
 (17.6 miles away)
888-287-1082
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Kim Eagle is a Cardiologist in Ann Arbor, Michigan. Dr. Eagle is highly rated in 40 conditions, according to our data. His top areas of expertise are Aortic Dissection, Marfan Syndrome, Thoracic Aortic Aneurysm, Cardiac Ablation, and Percutaneous Coronary Intervention (PCI).

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Dunn's expertise for a condition
ConditionClose
      View All 37 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile